The goal of this program is to improve management of patients with hematologic malignancies who require transfusion of blood products and management of myelodysplastic syndrome (MDS). After hearing and assimilating this program, the clinician will be better able to: 1. Monitor platelet refractoriness in patients with human leukocyte antigen alloimmunization using serial panel reactive antibody testing. 2. Optimize use of red blood cells in patients with acute myeloid leukemia. 3. Cite differences in the World Health Organization classification and the International Consensus Classification of MDS. 4. Summarize the benefits of using genomic information to stratify risk in patients with MDS. 5. Identify current and emerging therapies used for management of low- and high-risk MDS.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2023-05-10 05:00:00
- End Date: 2023-05-10 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology